About
MagForce NT GmbH is a medical technology company based in Berlin, Germany, specializing in innovative cancer treatments using nanotechnology. The company has developed the NanoTherm® Therapy System (NTTS), which is the first nanotechnology-based therapy approved in Europe for treating recurrent glioblastoma, a highly aggressive brain tumor. The NanoTherm® Therapy System utilizes magnetic nanoparticles to create localized hyperthermia within tumors, enhancing the effectiveness of cancer treatment while protecting surrounding healthy tissue. This minimally invasive approach has been supported by extensive research at the Charité hospital in Berlin and has been authorized for use since 2010. MagForce NT GmbH provides this therapy at specialized treatment centers across Germany, including major university hospitals in cities like Berlin, Münster, and Cologne. With a dedicated team of 11-50 employees, MagForce NT GmbH is expanding its presence in Europe and North America, aiming to make its advanced cancer treatment accessible worldwide. The company is committed to improving the quality of life for glioblastoma patients through its innovative therapy.
Keywords
Company Information
-
Employees 40
-
Founded 1997
Location
3 Max-Planck-Strasse, Berlin, Berlin, Germany, 12489
